Aditxt, Inc. Reports Board Changes and Shareholder Nominations
Ticker: ADTX · Form: 8-K · Filed: Aug 8, 2025 · CIK: 1726711
Sentiment: mixed
Topics: governance, board-changes, shareholder-activism
Related Tickers: ADTX
TL;DR
Aditxt board shakeup, shareholder nominations filed. Big changes coming?
AI Summary
Aditxt, Inc. announced on August 7, 2025, changes related to its board of directors and officers, including the election of new directors and potential changes in officer compensation. The filing also addresses shareholder nominations under Exchange Act Rule 14a-11, indicating potential proxy contests or significant shareholder engagement.
Why It Matters
Changes in board composition and officer roles can signal strategic shifts or governance adjustments within the company, while shareholder nominations suggest active investor interest and potential influence on corporate direction.
Risk Assessment
Risk Level: medium — The filing indicates potential governance changes and active shareholder engagement, which can introduce uncertainty and volatility.
Key Players & Entities
- Aditxt, Inc. (company) — Registrant
- August 7, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-39336 (filing_id) — SEC File Number
- 82-3204328 (ein) — IRS Employer Identification No.
- Exchange Act Rule 14a-11 (regulation) — Shareholder nominations
FAQ
What specific changes were made to the board of directors and officer positions?
The filing indicates the election of directors and appointment of certain officers, along with potential changes to compensatory arrangements, but does not detail the specific individuals or roles affected in this summary.
What is the significance of the shareholder nominations under Exchange Act Rule 14a-11?
This rule pertains to shareholder nominations for director, suggesting that shareholders are actively seeking to influence the composition of the board, potentially leading to proxy contests or significant governance discussions.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on August 7, 2025.
What is Aditxt, Inc.'s state of incorporation and SEC file number?
Aditxt, Inc. is incorporated in Delaware and its SEC file number is 001-39336.
What are the main items reported in this 8-K filing?
The main items reported are the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, as well as shareholder nominations pursuant to Exchange Act Rule 14a-11.
Filing Stats: 1,657 words · 7 min read · ~6 pages · Grade level 14.2 · Accepted 2025-08-08 16:15:32
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 ADTX The Nasdaq Stock Market LLC
Filing Documents
- ea025248301-8k_aditxt.htm (8-K) — 34KB
- 0001213900-25-073670.txt ( ) — 200KB
- adtx-20250807.xsd (EX-101.SCH) — 3KB
- adtx-20250807_lab.xml (EX-101.LAB) — 33KB
- adtx-20250807_pre.xml (EX-101.PRE) — 22KB
- ea025248301-8k_aditxt_htm.xml (XML) — 4KB
02. Departure of Directors or Certain Officers;
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 7, 2025, Jeffrey Runge, a member of the board of directors (the " Board ") of Aditxt, Inc. (the "Company") notified the Board that he will not stand for reelection at the 2025 Annual Meeting of Stockholders (the " 2025 Annual Meeting "). Dr. Runge will continue to serve as member of the Board and the Audit Committee, Nominating and Corporate and Governance Committee and the Compensation Committee until the expiration of his term. Dr. Runge's decision not to stand for reelection to the Board was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. On August 7, 2025, Saundra Pelletier, a member of the Board of Aditxt notified the Board that she will not stand for reelection at the 2025 Annual Meeting. Ms. Pelletier will continue to serve as a member of the Board until the expiration of her term. Ms. Pelletier's decision not to stand for reelection to the Board was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies, practices or the currently contemplated transaction (the " Merger ") between the Company and Evofem Biosciences, Inc. (" Evofem ") pursuant to that certain Amended and Restated Merger Agreement by and between the Company, Adifem, Inc. f/k/a Adicure, Inc. (" Adifem ") and Evofem dated July 12, 2024 (the " A&R Merger Agreement "). As contemplated under the A&R Merger Agreement, it is expected that Ms. Pelletier, who currently serves as President and Executive Director of Evofem, will be appointed to the Board and as President of Adifem following the closing of the Merger. Following the 2025 Annual Meeting, the size of the Board will be reduced from seven to five members.
08. Shareholder
Item 5.08. Shareholder Director Nominations. On August 7, 2025, the Board of Directors of the Company resolved to hold its 2025 Annual Meeting on September 16, 2025. The 2025 Annual Meeting will be held virtually online by means of remote communication. The record date for the 2025 Annual Meeting is August 8, 2025. Stockholders owning the Company's common stock at the close of business on the record date, or their legal proxy holders, are entitled to vote at the 2025 Annual Meeting. The Company, however, reserves the right to change the record date or the meeting date. Because the date of the 2025 Annual Meeting has been changed by more than 30 days from the anniversary of the date of the Company's 2024 Annual Meeting of Stockholders (the " 2024 Annual Meeting "), the deadline for stockholders' nominations or proposals for consideration at the 2025 Annual Meeting set forth in the Company's proxy statement for the 2024 Annual Meeting no longer applies. As such, the Company is filing this Current Report on Form 8-K to inform stockholders of this change and to provide the due date for the submission of any qualified stockholder proposals or qualified stockholder director nominations. Stockholders of the Company who wish to have a proposal considered for inclusion in the Company's proxy materials for the 2025 Annual Meeting pursuant to Rule 14a-8 under the Exchange Act (" Rule 14a-8 ") must ensure that such proposal is delivered or mailed to and received by the Company's Corporate Secretary at Aditxt, Inc., 2569 Wyandotte Street, Suite 101, Mountain View, CA 94043, no later than August 18, 2025, which the Company has determined to be a reasonable time before it expects to begin to print and distribute its proxy materials. Such proposals must comply with all applicable procedures and requirements of Rule 14a-8. Any stockholder who intends to submit a director nomination or who intends to submit a proposal regarding any other matter of business at the 2025 Annual